Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EV-077 in Type 2 Diabetic Subjects
This study is currently recruiting participants.
Verified March 2012 by Evolva SA
Study NCT01551381   Information provided by Evolva SA

First Received on March 8, 2012.   Last Updated on March 12, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type 2 Diabetes
Additional conditions recognized in this trial
Diabetes Mellitus, Type 2
More general conditions related to this trial
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
EV-077
Sponsors listed in this trial
Evolva SA


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services